All ECB deals limit 1 unless noted. Sign up for CVS email and get $4 ECB!
Dawn $0.97
-$0.2/1 Dawn PG 8/1
Total = $0.77
Kellogg’s Raisin Bran, Corn Flakes, Corn Pops, etc Cereal $2
-$1.25/3 Kelloggs Cereal RP 6/27
-$1/3 Kelloggs Cereal printable
-Various Kelloggs printable
Total = as low as $1.5
Kellogg’s Pop Tarts, Rice Krispies Treats $2
-$1/2 Kelloggs Pop Tarts RP 6/13, 7/11 or printable
Total = $1.5
Sobe or Gatorade B1G1 Free
-B1G1 Free Sobe Lifewater printable
Total = 2 free
Altoids $1.49, get $1 ECB
Total = $0.49 (great price!)
Buy $10 Crest, Oral-B or Scope shown, get $5 ECB (limit 2)
Best deal: Buy (3) Crest Pro-Health Rinse 1L $3.99, use (3) $2/1 Crest Mouthwash PG 8/1
Get $5 ECB = $0.97 for (3)
Buy $10 Band-Aid, Johnson & Johnson or Neosporin starting $2.99, get $5 ECB
-Various Neosporin, Band-Aid RP 6/20
-$2/1 Johnson’s Red Cross Hospital Grade Non-stick Pads printable
-$3/2 Johnson’s Red Cross Brand printable
Olay Regenerist $18.99, get $4 ECB
-$3/1 Olay Regenerist PG 7/4
-$5/1 Olay Regenerist P&G $100 Year of Savings Coupon Book
-Olay $20 Mail In Rebate wyb $50 Facial Moisturizers, etc
Total = as low as $9.99
Conair Hair or Shaving Appliances starting $4.29, get $5 ECB
Total = as low as FREE
Buy $15 Neutrogena or Clean & Clear skin products listed, get $5 ECB
-$1/1 Neutrogena Cleansing product All You Magazine August 2010
-$2/1 Clean & Clear printable
-Various Neutrogena SS 6/13, 7/11
-$5/1 Neutrogena Clinical printable
-$5 /1 Clean & Clear Morning Burst Shower Cleanser printable
-$5/1 Clean & Clear Advantage Acne Control printable
Gillette ProGlide, Venus Embrace or Breeze razor $9.79, get $5 ECB
-$4/1 Gillette Fusion Proglide PG 8/1
Total = $0.79
Colgate Total Advanced or Enamel Strength $2.99, get $2 ECB
-$0.75/1 Colgate Total Toothpaste printable
Total = $0.24
Fuze Drink 4/$5, get $5 ECB wyb $10 (unadvertised deal)
Look for $0.75/1 tearpad coupons near the drinks
Total = as low as free (thanks STLmommy)
I haven’t tried this deal yet but if you like Fuze drink it’ll be worth a shot!
Related posts:
Comments on this entry are closed.